Delivery Order SPE2DB22D2006-SPE2DB25FW1TC
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,291.53 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a medical product. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,615.38 firm-fixed price delivery order is for the pharmaceutical product Naropin 0.5% 100 mg/20 ml vial, 20 ml, with a performance period ending on December 17, 2024. The contract award was not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,361.71 firm fixed-price delivery order covers the supply of NAROPIN 0.2% 400 MG/200 ML BTL 200ML, a specialty pharmaceutical product, with a performance period ending on August 30, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of NAROPIN 0.2% 400 MG/200 ML BTL 200ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract, valued at $5,214.94, was awarded on September 21, 2022, with a completion date of September 22, 2022. It is a delivery order contract with a firm fixed price pricing type. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,805.82 firm fixed-price delivery order contract is for the provision of 4564431836 ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a medical product. The contract has an ultimate completion date of April 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,826.63 Firm Fixed Price Delivery Order is for the pharmaceutical product "ROPIVACAINE 0.5% 150 MG/30 ML 30ML" with a period of performance through February 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp is a $1,837.56 firm fixed-price delivery order from the Defense Logistics Agency (DLA), a defense agency. The contract is not set aside and provides for the delivery of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product, with a period of performance through June 13, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999.00 Indefinite Delivery Contract...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ROPIVACAINE 0.2% 200 MG/100 ML 100ML. The award, valued at $1,634.70, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and runs through February 13, 2025. The award is not subject to any set-aside requirements. Amerisourcebergen holds a...
This federal contract award is for a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for NORA-BE TABLET 28S, with a firm fixed price of $1,288.07 and a completion date of May 21, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,832.75 firm fixed price delivery order is for 4566601078 ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a specialty medication, with a performance period through December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...